FDA Approves Mesoblast Ryoncil
Filed with ASX · · 4 pages · English
Watch Mesoblast's latest callMesoblast (ASX:MSB) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mesoblast (ASX:MSB) Q4 2026 Earnings CallEarlier from Mesoblast
- Material Announcement
- Pause in Trade
- FDA Grants Mesoblast RMAT Designation
- Response to ASX Price Query
- Class Action Resolution
Later from Mesoblast
- Pause in Trading
- Trading Halt
- Mesoblast raises new capital for RYONCIL commercial launch
- Ryoncil Commercial Launch Update and Product Pipeline
- Dr. Gregory George MD PhD Joins Mesoblast Board
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast